Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Trauner

Showing results (661-670 of 777) with videos related to

Pageof 78
Sort By:
Hepatology International|May 22, 2021
The differential activation of cardiovascular hormones across distinct stages of portal hypertension predicts clinical outcomesLukas Hartl, Mathias Jachs, Christopher Desbalmes, et al.
JHEP Reports : Innovation in Hepatology|March 5, 2026
Non-invasive tests to guide hepatocellular carcinoma surveillanceJan Embacher, Katharina Remih, Carolin Victoria Schneider, et al.
European Journal of Radiology|November 2, 2025
Correlation between MRI-derived and biopsy-confirmed liver iron concentration in patients with chronic liver diseaseSami A Ba-Ssalamah, Michael Schwarz, Sarah Poetter-Lang, et al.
RMD Open|October 19, 2022
A systematic literature review informing the consensus statement on efficacy and safety of pharmacological treatment with interleukin-6 pathway inhibition with biological DMARDs in immune-mediated inflammatory diseasesKastriot Kastrati, Daniel Aletaha, Gerd R Burmester, et al.
Journal of Pediatric Gastroenterology and Nutrition|July 29, 2017
Cystic Fibrosis-related Liver Disease: Research Challenges and Future PerspectivesDominique Debray, Michael R Narkewicz, Frank A J A Bodewes, et al.
Hepatology International|April 15, 2026
Impact of pharmacological sGC stimulation with Riociguat in experimental models of liver disease regressionKatharina Bonitz, Philipp Königshofer, Henriette Horstmeier, et al.
BMC Medicine|July 23, 2016
Low levels of IgM antibodies recognizing oxidation-specific epitopes are associated with human non-alcoholic fatty liver diseaseTim Hendrikx, Martin L Watzenböck, Sofie M A Walenbergh, et al.
Gastroenterology|July 13, 2023
Dynamics in Liver Stiffness Measurements Predict Outcomes in Advanced Chronic Liver DiseaseGeorg Semmler, Zhenwei Yang, Laurenz Fritz, et al.
Gastroenterology|December 16, 2014
Efficacy of obeticholic acid in patients with primary biliary cirrhosis and inadequate response to ursodeoxycholic acidGideon M Hirschfield, Andrew Mason, Velimir Luketic, et al.
Hepatology (Baltimore, Md.)|December 17, 2013
SIRT1 controls liver regeneration by regulating bile acid metabolism through farnesoid X receptor and mammalian target of rapamycin signalingJuan L García-Rodríguez, Lucía Barbier-Torres, Sara Fernández-Álvarez, et al.
Pageof 78

Showing results (661-670 of 777) with videos related to

Sort By:
Pageof 78
Hepatology International|May 22, 2021
The differential activation of cardiovascular hormones across distinct stages of portal hypertension predicts clinical outcomesLukas Hartl, Mathias Jachs, Christopher Desbalmes, et al.
JHEP Reports : Innovation in Hepatology|March 5, 2026
Non-invasive tests to guide hepatocellular carcinoma surveillanceJan Embacher, Katharina Remih, Carolin Victoria Schneider, et al.
European Journal of Radiology|November 2, 2025
Correlation between MRI-derived and biopsy-confirmed liver iron concentration in patients with chronic liver diseaseSami A Ba-Ssalamah, Michael Schwarz, Sarah Poetter-Lang, et al.
RMD Open|October 19, 2022
A systematic literature review informing the consensus statement on efficacy and safety of pharmacological treatment with interleukin-6 pathway inhibition with biological DMARDs in immune-mediated inflammatory diseasesKastriot Kastrati, Daniel Aletaha, Gerd R Burmester, et al.
Journal of Pediatric Gastroenterology and Nutrition|July 29, 2017
Cystic Fibrosis-related Liver Disease: Research Challenges and Future PerspectivesDominique Debray, Michael R Narkewicz, Frank A J A Bodewes, et al.
Hepatology International|April 15, 2026
Impact of pharmacological sGC stimulation with Riociguat in experimental models of liver disease regressionKatharina Bonitz, Philipp Königshofer, Henriette Horstmeier, et al.
BMC Medicine|July 23, 2016
Low levels of IgM antibodies recognizing oxidation-specific epitopes are associated with human non-alcoholic fatty liver diseaseTim Hendrikx, Martin L Watzenböck, Sofie M A Walenbergh, et al.
Gastroenterology|July 13, 2023
Dynamics in Liver Stiffness Measurements Predict Outcomes in Advanced Chronic Liver DiseaseGeorg Semmler, Zhenwei Yang, Laurenz Fritz, et al.
Gastroenterology|December 16, 2014
Efficacy of obeticholic acid in patients with primary biliary cirrhosis and inadequate response to ursodeoxycholic acidGideon M Hirschfield, Andrew Mason, Velimir Luketic, et al.
Hepatology (Baltimore, Md.)|December 17, 2013
SIRT1 controls liver regeneration by regulating bile acid metabolism through farnesoid X receptor and mammalian target of rapamycin signalingJuan L García-Rodríguez, Lucía Barbier-Torres, Sara Fernández-Álvarez, et al.
Pageof 78